Related Experiment Video
Updated: Jan 2, 2026
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
Compression therapy following ClariVein® ablation therapy: a randomised controlled trial of COMpression Therapy
Doireann P Joyce1, Stewart R Walsh1, Charyl J Q Yap2
1Department of Vascular Surgery, Galway University Hospital, Galway, Ireland.
Insights
This study investigates compression therapy after mechano-chemical ablation (MOCA) for varicose veins. Findings will clarify compression
Area of Science:
- Vascular Surgery
- Minimally Invasive Procedures
Background:
- Endovenous treatments for varicose veins are increasingly common.
- Uncertainty exists regarding the necessity and duration of post-procedure compression bandaging or hosiery.
- Research is needed to evaluate the clinical and cost-effectiveness of post-intervention compression.
Purpose of the Study:
- To examine the effect of compression therapy in patients undergoing mechano-chemical ablation (MOCA) for truncal incompetence of varicose veins using the ClariVein® device.
- To clarify the role and optimal duration of compression therapy following MOCA.
Main Methods:
- Prospective randomized study comparing compression (group A) versus no compression (group B).
- Primary endpoint: patient pain scores (visual analogue scale) for 10 days post-procedure.
- Secondary endpoints: compliance, quality of life, clinical effectiveness, bruising, phlebitis, return to activities, patient satisfaction, and 6-month occlusion rates.
Main Results:
- N/A
Conclusions:
- This study aims to provide clarity on the use of compression therapy after mechano-chemical ablation for varicose veins.
- Results will inform clinical practice guidelines regarding post-procedure compression management.
Background:
Endovenous treatment of varicose veins has increased in popularity over the last decade. There remains, however, a degree of uncertainty regarding the role of compression bandaging or hosiery following this intervention. The National Institute for Clinical Excellence Guideline Development Group has advocated further research to evaluate the clinical and cost-effectiveness of this post-procedure intervention. In addition to this, the duration of compression bandaging also warrants clarification.
Methods:
Ethical approval for the study was obtained from the Singhealth Centralised Institutional Review Board (CIRB Ref: 2017/2710). Consent to enter the study will be sought from each participant only after a full explanation has been given, an information leaflet offered and time allowed for consideration. Signed participant consent will be obtained. Patients will be randomised to either compression (group A) or no compression (group B). The primary aim of the study is to assess the patient's pain scores for the first 10 days post procedure using a visual analogue scale. Secondary aims include an assessment of patient compliance with compression, quality of life scores, clinical effectiveness, rates of bruising and phlebitis, time taken to return to normal activities, patient satisfaction and occlusion rate at 6 months.
Discussion:
The purpose of this study is to examine the effect of compression therapy in patients having mechano-chemical ablation (MOCA) therapy for truncal incompetence of their varicose veins using the ClariVein® device. This study may provide clarification on the role of compression therapy in patients undergoing MOCA.
Trial Registration:
ClinicalTrials.gov, NCT03685838. Registered on 26 September 2018.
